Access to medications and conducting clinical trials in LMICs.
Nat Rev Nephrol
; 11(3): 189-94, 2015 03.
Article
en En
| MEDLINE
| ID: mdl-25668002
ABSTRACT
Access to essential medications is limited in many low-to-middle income countries (LMICs) and those that are available may be prohibitively expensive to the general population. Clinical trials have been suggested as an approach to improve drug access in LMICs but the number of trials conducted in these countries is small because of regulatory issues and a lack of infrastructure. In this article, Nature Reviews Nephrology asks three experts their opinions on how to improve drug access and increase the numbers of clinical trials conducted in LMICs.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Ensayos Clínicos como Asunto
/
Países en Desarrollo
/
Medicamentos bajo Prescripción
Aspecto:
Determinantes_sociais_saude
Límite:
Humans
Idioma:
En
Revista:
Nat Rev Nephrol
Asunto de la revista:
NEFROLOGIA
Año:
2015
Tipo del documento:
Article
País de afiliación:
Sudáfrica